Gelteq (GELS) Current Leases (2023 - 2025)

Gelteq (GELS) recorded quarterly Current Leases of $494084.0 in Q2 2025, down 40.94% quarter-over-quarter from $836530.8 in Q4 2024.

Gelteq (GELS) Current Leases (2023 - 2025) Analysis & Trends

Gelteq's Current Leases history runs 3 years deep, the most recent figure standing at $494084.0 for Q2 2025.

In Q2 2025, Current Leases changed N/A year-over-year to $494084.0; the TTM figure through Jun 2025 stood at $494084.0 (changed N/A YoY), while the FY2025 annual figure was $494084.0, changed N/A from the prior year.
Current Leases was $494084.0 for Q2 2025 at Gelteq, down from $836530.8 in the prior quarter.
In the past five years, Current Leases ranged from a high of $836530.8 in Q4 2024 to a low of $7950.8 in Q2 2023.
Historically, Current Leases has averaged $446188.5 across 3 years, with a median of $494084.0 in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	23.81 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	7.58 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	5.58 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-
10	Gelteq	10.57 Mn	10.34 Mn	-	494,083.97

Download Data